Similarly, it has been demonstrated that oroxylin A reduces cognitive impairment brought on by the permanent blockage of bilateral common carotid arteries (2VO) by suppressing activated microglia and upregulating the expression of CREB and brain-derived neurotrophic factor (BDNF) [45]. This evidence concerns the gene CREB1 and Cognitive impairment.